Posts

Synbiotic Health Team Welcomes Mallory Van Haute as Lab Scientist

With a decade’s experience in food and microbiology, Van Haute will help execute on Synbiotic Health’s ambitious R&D program

LINCOLN, Neb.  – October 1, 2021 – Microbiome-based ingredient company Synbiotic Health welcomes team member Mallory Van Haute this week in the role of Laboratory Scientist. Van Haute brings ten years’ scientific experience in food and gastrointestinal microbiology, having worked in multiple academic laboratories at University of Nebraska – Lincoln. She has been Research Manager at the Nebraska Food for Health Center and has more than a dozen peer-reviewed publications.

In the role of Scientist at Synbiotic Health, Van Haute will report to CSO Dr. Zac Lewis and carry out research and development activities in the company’s innovation pipeline. She will lead lab work and bioinformatic projects to guide product development and deliver new health-promoting ingredients to market. She holds an M.S. in Food Science & Technology from University of Nebraska – Lincoln and is nearing completion of her Ph.D.

“Mallory has worked closely with some of our founders for many years, and brings exceptional knowledge and experience in diet-microbiome interactions to our team” says CSO Dr. Zac Lewis. “We could not be happier that she is joining us. Her presence increases our capacity to discover new ecologically advanced probiotic strains, design intelligently paired synbiotics, and rationally target the aspects of human health where our product development approach will yield superior results for consumers.

About Synbiotic Health

Synbiotic Health was founded in 2018 by four well-known microbiome research scientists to develop targeted microbiome ingredients to support health. Based on over 10 years of research, Synbiotic Health will develop and commercialize Ecologically Advanced Probiotics™ as well as rationally designed Synergistic Synbiotics™.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other microbiome-based ingredients interact with and influence the resident microbes in the gut. Synbiotic Health’s approach considers the entire ecosystem and the specific traits and functions necessary for microbiome-altering ingredients to perform and improve human health.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic™ – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Kristina Campbell

Kristina@synbiotichealth.com

Thomas Auchtung, PhD, joins Synbiotic Health as Lab Manager

Experienced microbiologist to manage the company’s microbiome-focused research and development platform

LINCOLN, Neb.  – August 3, 2021 – Microbiome-based ingredient company Synbiotic Health is pleased to welcome Dr. Thomas Auchtung to the team in the key role of Laboratory Manager. Auchtung comes to Synbiotic Health with a wealth of microbiology research experience and scientific talent. He holds a PhD from Harvard University and joins the company after spending three years as Research Assistant Professor in the Department of Food Science and Technology at University of Nebraska-Lincoln.

Auchtung will manage internal laboratory operations and external testing to execute on the company’s product development and improvement strategy, as the company prepares to release its first commercially available ingredient, the iVS-1 Advanced Probiotic™ strain. The author of 19 peer-reviewed publications, Auchtung has previously worked in the labs of Joseph Petrosino at Baylor College of Medicine, Robert Britton at Michigan State University, Colleen Cavanaugh at Harvard University, Alan Grossman at MIT, and Robert Hausinger at Michigan State University.

“Tommy brings an impressive breadth of scientific experience from working in leading academic labs,” says Zac Lewis, CSO of Synbiotic Health. “We are delighted to have him join our growing company to help develop our unique portfolio of ecologically-designed ingredients. Having him lead our internal discovery and bench research activities will let us continue to bring truly innovative and disruptive offerings to the market for the long term. This capability will help position us as the leading science-based and data-driven strain provider in the probiotic industry; delivering demonstrably superior ecology-based technology as envisioned by our founders.”

About Synbiotic Health

Synbiotic Health was founded in 2018 by four well-known microbiome research scientists to develop ecologically-advanced microbiome ingredients for improved health. Based on over 10 years of research, Synbiotic Health will commercialize Advanced Probiotics™ as well as Synergistic Synbiotics™ – complementary combinations of probiotics with fiber and/or prebiotics.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other microbiome-based ingredients interact with and influence the resident microbes in the gut. Synbiotic Health’s approach considers the entire ecosystem and the specific traits and functions necessary for microbiome-altering ingredients to perform and improve human health.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic™ – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Kristina Campbell

Kristina@synbiotichealth.com

Synbiotic Health appoints Steve Prescott, MBA, as Senior Vice President, Business Development / Operations

Probiotics industry veteran to lead business strategy for company’s growing product portfolio

LINCOLN, Neb.  – June 10, 2021 – Synbiotic Health, a rapidly growing microbiome nutritional ingredients company, is pleased to announce that Steve Prescott, MBA, has taken on the role of Senior Vice President, Business Development. Prescott has extensive experience in the probiotics industry, having served as Global VP – Marketing and Operations and Global Business Director for leading probiotic producers.

At Synbiotic Health, Prescott will refine and implement the company’s strategy for business operations as he oversees product development, sales and marketing. Initially he will focus on bringing the company’s first commercially available ingredient, iVS-1 Ecologically-Advanced Probiotic™, to market.

“With his broad experience in the industry, Steve Prescott is a great addition to our growing team,” said Tim Brummels, Synbiotic Health CEO. “He’s very knowledgeable about business strategy and has previously brought new products to market. Importantly, since Synbiotic Health is a company that sets itself apart through scientific innovation, his solid technical background will serve him well in this role.”Prescott previously held positions with Probi and DuPont, and has been working in the probiotics industry for 9 years. He holds an MBA from Michigan State University and a MS in Organic Chemistry from Iowa State University.

About Synbiotic Health

Synbiotic Health was founded in 2018 by four well-known microbiome research scientists to develop ecologically-advanced microbiome ingredients for improved health. Based on over 10 years of research, Synbiotic Health will commercialize advanced probiotics™ and synergistic synbiotics™ – complementary combinations of probiotics with fiber and/or prebiotics.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework. That is, how probiotics and other microbiome ingredients interact with and influence the resident microbes in the gut. At Synbiotic Health, its research considers the entire ecosystem and the specific traits and functions necessary for microbiome ingredients to perform and improve human health. The approach has led to novel discovery platforms as well as ecologically-advanced probiotic strains and synergistic synbiotics™.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Tim Brummels

t.brummels@synbiotichealth.com

 

 

Zac Lewis, PhD, Joins Team at Synbiotic Health as Chief Scientific Officer

Will lead its ‘ecologically-advanced’ microbiome research & development efforts

FOR IMMEDIATE RELEASE

LINCOLN, Neb.  – March 16, 2021 – Synbiotic Health is pleased to announce the addition of Dr. Zac Lewis as its Chief Scientific Officer. Dr. Lewis’s responsibilities will be to lead the build out and implementation of Synbiotic Health’s research & development program. Dr. Lewis will also serve as a liaison between Synbiotic Health’s Scientific Founders and its commercial efforts. A primary focus will be to develop and introduce microbiome-based ingredients using Synbiotic Health’s unique ‘ecological’ approach that has resulted in novel discovery platforms as well as ecologically-advanced probiotic strains and synergistic synbiotics™.

“We’re delighted to have Dr. Lewis join the team at Synbiotic Health,” said Tim Brummels, CEO/President with Synbiotic Health. “He brings the experience necessary to lead research efforts as well as commercialize our microbiome ingredients, and believes strongly in the value of using an ecological approach in product development.”

Dr. Lewis previously was an associate research fellow and microbiome subject matter expert with The Clorox Company working on the Renew Life brand, and has been involved in microbiome research for over 15 years. Dr. Lewis has authored or contributed to over 20 research publications and has spoken at a number of microbiome-related conferences. His key skill set includes probiotic and prebiotic product design, microbial ecology, bioinformatics, microbiology, and molecular biology. He holds a PhD in Microbiology from University of California, Davis and a BS in Microbiology from Brigham Young University.

About Synbiotic Health

Synbiotic Health was founded in 2018 by four noted microbiome research scientists to develop ecologically-advanced microbiome ingredients for improved health. Based on over 10 years of research, Synbiotic Health will commercialize advanced probiotics™ and synergistic synbiotics™ – complementary combinations of probiotics with fiber and/or prebiotics.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework. That is, how probiotics and other microbiome ingredients interact with and influence the resident microbes in the gut. At Synbiotic Health, its research considers the entire ecosystem and the specific traits and functions necessary for microbiome ingredients to perform and improve human health. The approach has led to novel discovery platforms as well as ecologically-advanced probiotic strains and synergistic synbiotics™.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Tim Brummels

t.brummels@synbiotichealth.com